Logo-jcs
J Caring Sci. 2015;4(3): 225-231. doi: 10.15171/jcs.2015.023
PMID: 26464839        PMCID: PMC4591610

Original Research

Psychosocial Factors Associated with Polycystic Ovary Syndrome: a Case Control Study

Manizheh Sayyah-Melli 1, Mahasti Alizadeh 2 * , Nosratollah Pourafkary 3, Elaheh Ouladsahebmadarek 1, Mehri Jafari-Shobeiri 1, Jaleh Abbassi 3, Maryam alsadat Kazemi-Shishvan 2, Kamran Sedaghat 4

Cited by CrossRef: 21

1- Morán-Sánchez I, Adoamnei E, Sánchez-Ferrer M, Prieto-Sánchez M, Arense-Gonzalo J, Carmona-Barnosi A, Hernandez-Peñalver A, Mendiola J, Torres-Cantero A. Assessment of Optimism in Women with Polycystic Ovary Syndrome: A Case Control-Study. IJERPH. 2021;18(5):2352 [Crossref]
2- ZHANG Q, LIU L. Correlation between psychological resilience and burnout among female employees in a shopping mall in Xi Xian New Area, China: A cross-sectional survey. J Integr Nurs. 2021;3(3):117 [Crossref]
3- Cooney L, Dokras A. Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment. Curr Psychiatry Rep. 2017;19(11) [Crossref]
4- Azizi M, Elyasi F. Psychosomatic Aspects of Polycystic Ovarian Syndrome: A Review. Iran J Psychiatry Behav Sci. 2017;11(2) [Crossref]
5- Chouhan S, Haldar A, Singh R, Shrivastava R. A pilot study to analyze the quality of sleep by pittsburgh sleep quality index in patients with polycystic ovary syndrome. J Appl Sci Clin Pract. 2021;2(1):22 [Crossref]
6- Wright P, Corbett C, Pinto B, Dawson R, Wirth M. The impact of exercise perceptions and depressive symptoms on polycystic ovary syndrome–specific health-related quality of life. Womens Health (Lond Engl). 2021;17:174550652110658 [Crossref]
7- Adamczak A, Płotek W, Głowińska A, Sobol M, Wysocka E, Polak G, Dymanowska-Dyjak I, Spaczyńska J, Adamczak Ł, Banaszewska B. Time Perspective as a Mediator of Depressive Symptoms in Patients with Polycystic Ovary Syndrome. Healthcare. 2023;11(7):993 [Crossref]
8- Tan J, Wang Q, Feng G, Li X, Huang W. Increased Risk of Psychiatric Disorders in Women with Polycystic Ovary Syndrome in Southwest China. 2017;130(3):262 [Crossref]
9- Scaruffi E, Franzoi I, Civilotti C, Guglielmucci F, La Marca L, Tomelini M, Veglia F, Granieri A. Body image, personality profiles and alexithymia in patients with polycystic ovary syndrome (PCOS). Journal of Psychosomatic Obstetrics & Gynecology. 2019;40(4):294 [Crossref]
10- Wang M, Liu M, Sun J, Jia L, Ma S, Gao J, Xu Y, Zhang H, Tsang S, Li X. MicroRNA-27a-3p affects estradiol and androgen imbalance by targeting Creb1 in the granulosa cells in mouse polycytic ovary syndrome model. Reproductive Biology. 2017;17(4):295 [Crossref]
11- Cooney L, Lee I, Sammel M, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. 2017;32(5):1075 [Crossref]
12- Ekramzadeh M, Hajivandi L, Noroozi M, Mostafavi F. Psychological experiences of adolescent girls with polycystic ovary syndrome: A qualitative study. Iranian J Nursing Midwifery Res. 2020;25(4):341 [Crossref]
13- Westerman R, Kuhnt A. Metabolic risk factors and fertility disorders: A narrative review of the female perspective. Reproductive Biomedicine & Society Online. 2022;14:66 [Crossref]
14- Zigarelli A, Jia Z, Lee H. Machine-Aided Self-diagnostic Prediction Models for Polycystic Ovary Syndrome: Observational Study. JMIR Form Res. 2022;6(3):e29967 [Crossref]
15- Standeven L, Olson E, Leistikow N, Payne J, Osborne L, Hantsoo L. Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone. Curr Psychiatry Rep. 2021;23(6) [Crossref]
16- Basirat Z, Faramarzi M, Chehrazi M, Amiri M, Ghofrani F, Tajalli Z. Differences between infertile women with and without PCOS in terms of anxiety, coping styles, personality traits, and social adjustment: a case–control study. Arch Gynecol Obstet. 2020;301(2):619 [Crossref]